Biobanks & Disease Registries

Your message has been received.

Thank you for connecting with Manifold.

Our team will follow up soon to discuss your inquiry. We look forward to learning more about your organization and how we can support your goals.

Latest Insights from Manifold

We publish insights on biobank enablement, registry strategy, AI-driven research, and innovative data collaborations across healthcare.

Four Things I Heard at DataDrivenPharma That Matter

Insights from DataDrivenPharma reveal a clear shift in life sciences: AI is moving beyond experimentation toward practical, team-centered workflows that enhance expert decision-making rather than replace it. The future lies in narrow, transparent agents, deeper domain expertise, and scaling pilots into responsible, production-ready systems that unlock real scientific impact.

Accelerating Breast Cancer Research: Komen Tissue Bank Partners with Manifold to Advance Phenotypic Insights

Progress in understanding breast cancer has been limited by the lack of accessible normal breast tissue. The Komen Tissue Bank at Indiana University Melvin and Bren Simon Comprehensive Cancer Center uniquely fills this gap as the world’s only repository of normal breast tissue from healthy volunteers. Through its partnership with Manifold, this resource will become broadly accessible as a global breast cancer research commons.

Rewriting the Future of Life Sciences: Our Series B and What Comes Next

Life sciences has never had more powerful tools—yet progress is slowing when it should be accelerating. Manifold’s CEO lays out why this gap exists, how vertical AI can close it, and what our Series B enables as we build the platform to move the field forward.